AI implementation that is built on strategy from day one — not retrofitted to it afterwards

Two decades of pharmaceutical AI implementation — which means we have encountered every obstacle your programme is likely to face, and we know exactly how to navigate them.

When Eularis began delivering AI-powered solutions in biopharma in 2003, the vendor ecosystem that exists today did not yet exist. There were no established implementation partners to engage, no proven frameworks to follow, and no industry playbook to reference. Eularis built its implementation capability from the ground up — which means that everything our team knows about pharmaceutical AI implementation has been learned through direct experience, not inherited from another industry or adapted from a generic technology framework.
Two decades later, that foundation is the most valuable thing we bring to an implementation engagement. We have encountered the obstacles. We know where projects stall. We know how to navigate regulatory and compliance requirements that most implementation firms encounter for the first time with their first pharma client. And we know how to connect every implementation decision back to the commercial strategy it is supposed to serve.

Every Eularis implementation engagement follows the same structured sequence — from AI Strategic Blueprint through to deployment, serving, and ongoing insights analysis. The full process is shown in the diagram below.
Clients engage us at different points in that journey. Some come to us for the strategic blueprint alone. Others bring us in at the deployment planning stage. And others engage Eularis for the complete end-to-end process — from initial strategic analysis through to a fully operational, commercially connected AI solution.

Wherever you are in the journey, the engagement connects to the same underlying principle: every implementation decision must be traceable back to a specific commercial priority. We do not build AI solutions that are technically impressive but strategically disconnected.

The eight stages of the Eularis end-to-end implementation

The Eularis end-to-end implementation covers eight integrated stages — each one designed to ensure that what is built is strategically sound, commercially connected, and operationally deployable inside a pharmaceutical organisation:

AI Strategic Blueprint — Establishing the precise commercial challenges the implementation will solve and the measurable outcomes it will be held accountable to. Every subsequent decision flows from this foundation.
AI Discovery Blueprint — Translating the strategic priorities into a detailed technical architecture — identifying the right data, the right approach, the right vendors, and the right governance framework before a single line of code is written.
MVP and Pilot Delivery — Building and testing a minimum viable version of the solution against real organisational conditions — validating the approach before full investment is committed.
Model Operationalisation — Preparing the solution for deployment inside the pharmaceutical organisation’s specific infrastructure, compliance requirements, and operational workflows.
Model Deployment — Moving from pilot to production — ensuring the solution is fully integrated, adopted by the teams who need to use it, and performing against the commercial metrics it was designed to move.
Model Serving — Maintaining the solution’s performance in a live environment — monitoring, updating, and optimising as conditions change and new data becomes available.
Insights Analysis — Translating the outputs of the deployed solution into clear commercial intelligence that leadership teams can act on confidently.
Predictions Assessment — Continuously evaluating the accuracy and relevance of the model’s outputs — ensuring the solution remains aligned to commercial reality as the market evolves.

"Your team seem as organized and resourced as one could possibly hope for. You are an indomitable machine. Thank you for your and your team’s efforts."

"Thank you very much. Very comprehensive and very impressive."

"I worked closely with Andree and the team at Eularis on a 4-month project. Andree has the unique ability to quickly get up to speed on an organization's strategic focus and distill complex information into a simplified format that allows a leadership team to provide appropriate input and guidance. I always looked forward to our weekly calls and learned something new in every single one. She is well organized, asks insightful questions, and has a knowledge of AI and the pharmaceutical industry that is unparalleled. The output of our project was high value for our entire organization, and I look forward to working with Andree again."

“I wanted you to know that my VP again mentioned that he was impressed by the project and the buzz it has created in the organization!! So, we should feel very good about how this went! Anyways, thanks for really partnering with me on this.”

Ready to discuss what end-to-end implementation looks like for your specific challenge?

Give us your most difficult challenges to solve with the optimal AI and FutureTech!

To solve difficult challenges, you often need sophisticated technology. You know the challenges you face. The question is how to solve them. We provide a deep dive into where the opportunities are and then identify the optimal AI or FutureTech-enabled approach to give real-world measurable results that solve your specific challenge. Not just any AI, but an approach that solves your most pressing business challenge/s effectively. This can include being able to access new data sets, advanced artificial intelligence algorithms, APIs to connect old and new, and disruptive technologies to quickly solve challenges. We then assess the cost/feasibility and identify the use case/s and options to de-risk implementation and identify the optimal growth paths. This Lab enables you to solve your most complex challenge with AI/FutureTech.